telehealth.helpFind my match

Home WikiTelehealth Concepts

Body mass index (BMI)

From WikiTelehealth, the telehealth.help reference · Last updated

Body mass index (BMI) is a number calculated from a person's weight and height, used to screen adults for underweight, overweight and obesity. FDA labels for GLP-1 weight-loss medicines use BMI cutoffs of 30, or 27 with a weight-related health condition, to define who the drugs are approved for.

Body mass index (BMI)
TypeScreening measure
Formulakg / m², or 703 x lb / in²
Healthy weight18.5 to under 25
Overweight25 to under 30
Obesity30 or greater
GLP-1 label cutoffs30, or 27 with a weight-related condition

Formula

BMI is weight in kilograms divided by height in meters squared. In US units, BMI equals weight in pounds divided by height in inches squared, multiplied by 703. For example, a person who is 5 feet 6 inches tall (66 inches) and weighs 186 pounds has a BMI of about 30.

The same BMI categories apply to all adults aged 20 and older, regardless of age or sex. Children and teens aged 2 to 19 use BMI-for-age percentiles instead.

Adult categories

The CDC uses these adult BMI categories. Underweight is below 18.5. Healthy weight is 18.5 to under 25. Overweight is 25 to under 30. Obesity is 30 or greater.

Obesity is split into three classes. Class 1 is a BMI of 30 to under 35, class 2 is 35 to under 40, and class 3 is 40 or greater. Class 3 is also called severe obesity. See obesity for how common each level is in the United States.

Use in GLP-1 weight-loss labels

FDA labels for weight-loss medicines such as Wegovy and Zepbound describe the adults they are approved for using BMI. These are adults with obesity (BMI of 30 or greater), or adults with overweight (BMI of 27 or greater) who also have at least one weight-related condition. Examples of such conditions include high blood pressure, type 2 diabetes and high cholesterol.

A prescriber decides whether a medicine fits each person, using BMI along with health history. Our GLP-1 eligibility quiz shows how these cutoffs apply. Medicines in this group are described in semaglutide and tirzepatide.

Limits of BMI

The CDC describes BMI as a screening measure, not a diagnosis. BMI does not measure body fat directly. It cannot tell muscle from fat, so a very muscular person may have a high BMI with little body fat. It also does not show where fat is stored. Fat around the waist is linked to higher health risk than fat in other areas.

For these reasons, clinicians often look at BMI together with waist size, blood pressure, blood sugar, cholesterol and other health factors.

Check if you may qualify for a GLP-1

See also

References

  1. CDC, Adult BMI categories. cdc.gov
  2. NIDDK, Prescription medications to treat overweight and obesity. niddk.nih.gov
  3. Zepbound (tirzepatide) prescribing information, Drugs@FDA. accessdata.fda.gov

Last updated . Category: Concepts. Browse all 38 WikiTelehealth entries.